NRx Pharmaceuticals Unveils Breakthrough Ketamine Formulation for Pain-Free Administration
RADNOR, PA — NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), in collaboration with Nephron Pharmaceuticals, has announced the development of a novel formulation of IV Ketamine, known as HTX-100, that achieves a …
NRx Pharmaceuticals Unveils Breakthrough Ketamine Formulation for Pain-Free Administration Read More